Goodwin wins lucrative work on Moderna’s massive IPO


The biotech expects to incur $5 million in legal expenses related to its upcoming offering, significantly more than many other local IPOs.

Previous Direct primary care yields corporate profitability
Next Why Steve Tang will ring NASDAQ's opening bell on World AIDS Day